Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 1
2021 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia.
Avendaño-Solá C, Ramos-Martínez A, Muñez-Rubio E, Ruiz-Antorán B, Malo de Molina R, Torres F, Fernández-Cruz A, Calderón-Parra J, Payares-Herrera C, Díaz de Santiago A, Romera-Martínez I, Pintos I, Lora-Tamayo J, Mancheño-Losa M, Paciello ML, Martínez-González AL, Vidán-Estévez J, Nuñez-Orantos MJ, Saez-Serrano MI, Porras-Leal ML, Jarilla-Fernández MC, Villares P, de Oteyza JP, Ramos-Garrido A, Blanco L, Madrigal-Sánchez ME, Rubio-Batllés M, Velasco-Iglesias A, Paño-Pardo JR, Moreno-Chulilla JA, Muñiz-Díaz E, Casas-Flecha I, Pérez-Olmeda M, García-Pérez J, Alcamí J, Bueno JL, Duarte RF; ConPlas-19 Study Group. Avendaño-Solá C, et al. J Clin Invest. 2021 Oct 15;131(20):e152740. doi: 10.1172/JCI152740. J Clin Invest. 2021. PMID: 34473652 Free PMC article. Clinical Trial.
Validation of R-MIPI and prognostic value of immunoglobulin light chain restriction in mantle cell lymphoma.
Villegas Da Ros C, Linares Garcia M, Ortiz Zuluaga S, Javier Gonzalez K, Costa S, Roig M, Perez Rodriguez PL, Orero Castello M, Luna I, López-Pavía M, Sanchez M, Carbonell F. Villegas Da Ros C, et al. Br J Haematol. 2017 Jun;177(5):816-818. doi: 10.1111/bjh.14109. Epub 2016 Apr 29. Br J Haematol. 2017. PMID: 27125335 Free article. No abstract available.
Factors related to the development of high antibody titres against SARS-CoV-2 in convalescent plasma donors from the ConPlas-19 trial.
Romera Martínez I, Avendaño-Solá C, Villegas Da Ros C, Bosch Llobet A, García Erce JA, González Fraile MI, Guerra Domínguez L, Vicuña Andrés I, Anguita Velasco J, González Rodríguez VP, Contreras E, Urcelay Uranga S, Pajares Herraiz ÁL, Jimenez-Marco T, Ojea Pérez AM, Arroyo Rodríguez JL, Pérez-Olmeda M, Ramos-Martínez A, Velasco-Iglesias A, Bueno Cabrera JL, Duarte RF. Romera Martínez I, et al. Among authors: villegas da ros c. Vox Sang. 2024 Jan;119(1):27-33. doi: 10.1111/vox.13561. Epub 2023 Nov 20. Vox Sang. 2024. PMID: 37986640
Pathogen reduction with methylene blue does not have an impact on the clinical effectiveness of COVID-19 convalescent plasma.
Romera Martínez I, Bueno Cabrera JL, Domingo-Morera JM, López Aguilar JC, Villegas Da Ros C, García Erce JA, Sáez Serrano I, Flores Ballester E, Maglio LA, Arbona Castaño C, Sola Lapeña C, Guerra Domínguez L, Berberana Fernández M, Madrigal Sánchez ME, Rubio Batllés M, Pérez-Olmeda M, Ramos-Martínez A, Velasco-Iglesias A, Avendaño-Solá C, Duarte RF. Romera Martínez I, et al. Among authors: villegas da ros c. Vox Sang. 2023 Apr;118(4):296-300. doi: 10.1111/vox.13406. Epub 2023 Feb 3. Vox Sang. 2023. PMID: 36734378 Clinical Trial.